Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease

Abstract

CTM increased appetite and resulted in weight gain in CKD cats despite significant inconsistencies in compounding, and may benefit cats in countries where an approved product is not available.